Clinical Trial

Sarcopenia in Chronic Kidney Disease (CKD) Patients

Study acronym: BOOST_CKD
Not Yet Recruiting Early Phase 1
View on ClinicalTrials.gov →
Summary
Sarcopenia, or loss of muscle and strength is common in patients with poor kidney function. Although a high protein diet is generally recommended for sarcopenia, patients with poor kidney function are advised to follow a low-protein diet. In this study, we will evaluate the practicality and potential benefits of two different amino acids (molecules that form proteins) in improving sarcopenia in patients with advanced kidney disease. The study aims to improve muscle mass and strength. All study procedures are free of cost and do not require significant time commitment. You will have time to ask questions and discuss the study with your family, primary care physician, and your kidney doctor to make the decision if this is right study for you to participate in.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-02-20.
Trial Details
NCT Number NCT07437053
Lead Sponsor The University of Texas Health Science Center at San Antonio
Collaborators: National Institute on Aging (NIA)
Conditions Chronic Kidney Disease, Sarcopenia
Enrollment 20 participants
Start Date 2026-08-24
Primary Completion 2027-07-31 (estimated)
Study Completion 2027-10-30 (estimated)
Updated on ClinicalTrials.gov 2026-08-11